SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-20-000045
Filing Date
2020-08-11
Accepted
2020-08-11 16:53:03
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10q2020q2.htm   iXBRL 10-Q 1642703
2 EXHIBIT 10.2 alpn-ex10220200630.htm EX-10.2 887078
3 EXHIBIT 31.1 alpn-ex31120200630.htm EX-31.1 12526
4 EXHIBIT 31.2 alpn-ex31220200630.htm EX-31.2 12416
5 EXHIBIT 32.1 alpn-ex32120200630.htm EX-32.1 6970
6 EXHIBIT 32.2 alpn-ex32220200630.htm EX-32.2 7016
  Complete submission text file 0001626199-20-000045.txt   6217413

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20200630.xsd EX-101.SCH 33650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20200630_cal.xml EX-101.CAL 58317
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20200630_def.xml EX-101.DEF 127244
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20200630_lab.xml EX-101.LAB 447415
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20200630_pre.xml EX-101.PRE 238533
12 EXTRACTED XBRL INSTANCE DOCUMENT a10q2020q2_htm.xml XML 625827
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 201093104
SIC: 2834 Pharmaceutical Preparations